Mirati Marks Another Milestone With Adagrasib

US FDA Grants Breakthrough Designation

 
• By Alaric DeArment
  
Neon Light Sign Lungs Icon
Mirati received a breakthrough therapy designation from the FDA for KRAS G12C inhibitor adagrasib • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business